BlackRock Health Sciences Term Trust names Mahoney director

A new Form 3 identifies Francis C. Mahoney as a director of BlackRock Health Sciences Term Trust without reporting any current holdings or transactions.

Rhea-AI Filing Summary

BlackRock Health Sciences Term Trust (BMEZ) filed an initial ownership report indicating that Francis C. Mahoney is a director of the trust. The filing reports no securities transactions or holdings for Mahoney at this time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 3 filing mean for BlackRock Health Sciences Term Trust (BMEZ)?

The Form 3 identifies Francis C. Mahoney as a director of BlackRock Health Sciences Term Trust. It is an initial statement of beneficial ownership and does not report any current holdings or transactions by this director.

Does Francis C. Mahoney report any BMEZ share ownership on this Form 3?

No. The Form 3 for BlackRock Health Sciences Term Trust reports no securities holdings for Francis C. Mahoney as of the filing, and there are no holding entries listed.

Are there any buy or sell transactions reported in this BMEZ Form 3?

No. The filing shows no reported transactions for Francis C. Mahoney. Buy, sell, acquire, dispose, and other transaction counts are all reported as zero.

What role does Francis C. Mahoney have at BlackRock Health Sciences Term Trust (BMEZ)?

Francis C. Mahoney is reported as a director of BlackRock Health Sciences Term Trust. He is not reported as an officer or a ten percent owner in this Form 3.

Does the BMEZ Form 3 mention any Rule 10b5-1 trading plan for the director?

No. The document-level field for a Rule 10b5-1 trading plan is null, and there are no transactions or footnotes indicating that any trades were made under a trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 05:12 PM Accepted by SEC EDGAR 09/17/2026 - 05:11 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mahoney Francis C.

(Last) (First) (Middle)

50 HUDSON YARDS

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/08/2026

3. Issuer Name and Ticker or Trading Symbol
BlackRock Health Sciences Term Trust [ BMEZ ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Gladys Chang as Attorney-in-Fact	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)